SDAD1: Potential Drug Target Or Biomarker (G55153)

Target Name: SDAD1

NCBI ID: G55153

SDAD1

SDAD1: Potential Drug Target Or Biomarker

SDAD1 (Protein SDA1 homolog) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the SDA1 family, which includes several related proteins that play important roles in various cellular processes. One of the unique features of SDAD1 is its ability to interact with other proteins, including the protein known as CSN2, which is also known as bone marrow sialoprotegerin.

The CSN2 protein is a transmembrane protein that is expressed in many different tissues, including the bone marrow, where it is involved in the regulation of bone growth and development. CSN2 has been shown to play a role in the development and maintenance of cancer, as well as in the regulation of inflammation and fibrosis.

SDAD1 has been shown to interact with CSN2 in a number of different ways. For example, studies have shown that SDAD1 and CSN2 can form a complex in the cytosol of cells, where they can interact with each other directly. Additionally, SDAD1 has been shown to regulate the activity of CSN2, which suggests that it may play a role in the regulation of CSN2-related processes.

The potential implications of SDAD1 and CSN2 interactions are significant, as they suggest that this protein may be a drug target or biomarker. For example, if SDAD1 is found to be a drug target, it could be potential target for small molecules that are designed to inhibit its activity. Alternatively, if SDAD1 is found to be a biomarker, it could be used as a diagnostic tool for various diseases.

In addition to its potential as a drug target or biomarker, SDAD1 is also of interest as a potential therapeutic target for a number of different diseases. For example, studies have shown that SDAD1 is involved in the regulation of inflammation and fibrosis, which suggests that it may be a potential target for diseases that involve these processes. Additionally, SDAD1 has been shown to play a role in the regulation of cell survival and proliferation, which suggests that it may be a potential target for diseases that are characterized by these processes.

Overall, SDAD1 is a protein that has significant potential as a drug target or biomarker. Its interactions with other proteins, including CSN2, suggest that it may be a promising target for small molecules that are designed to inhibit its activity. Further research is needed to fully understand the role of SDAD1 in various cellular processes, as well as its potential as a therapeutic target.

Protein Name: SDA1 Domain Containing 1

Functions: Required for 60S pre-ribosomal subunits export to the cytoplasm

The "SDAD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDAD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets